More and more scientific and clinical evidence proves the effectiveness of stem cell therapies such as bone marrow concentrate (BMC).
BMC is a biological product that simultaneously provides growth factors, anti-inflammatory proteins and mesenchymal stem cells (MSCs).
It is this combination of proteins and biologically active cells that differentiates BMC from other treatments, including corticosteroids and PRP (growth factors), for various knee conditions.
Injections are performed in the operating room. As a general rule, bone marrow removal is done at the level of the iliac crest. The most commonly described method for obtaining cell concentrate (BMC) is centrifugation, which efficiently separates and concentrates white blood cells (leukocytes), MSCs, hematopoietic stem cells and platelets in one layer, and red blood cells in a second.
There is strong evidence that intra-articular BMC therapy can reduce the progression of knee osteoarthritis. Patients with severe osteoarthritis, after unsuitable medial meniscectomy benefited from stem cell injections (BMC) or growth factors (PRP)
In patients with general knee pain and osteoarthritis, Stem Cell Injection (BMC) has been shown to be safe and effective, with a significant reduction in pain.